The Klein Law Firm Reminds Investors of Class Actions

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
252
The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Micro Focus International plc, Recro Pharma, Inc., Aegean Marine Petroleum Network Inc.

NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Micro Focus International plc (NYSE: MFGP ) Lead Plaintiff Deadline: July 23, 2018 Class Period: September 1, 2017 – March 19, 2018, and August 4, 2017 or August 22, 2017

Allegations: The complaint alleges that the Registration Statement and Prospectus filed for the Company’s Initial Public Offering contained materially false and misleading information and/or failed to disclose material information, and that Micro Focus made materially false and misleading statements and/or failed to disclose material information throughout the class period.

Get additional information: http://www.kleinstocklaw.com/pslra-c/micro-fo...plc?wire=3 .

Recro Pharma, Inc. (NASDAQ: REPH ) Lead Plaintiff Deadline : July 30, 2018 Class Period: July 31, 2017 - May 23, 2018

Allegations: Recro Pharma made materially false and/or misleading statements or failed to disclose that: the Company's lead product, IV meloxicam, lacked supporting clinical data to show sufficient clinical benefits to receive U.S. Food and Drug Administration ("FDA") approval; and as a result, Recro Pharma's public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/recro-ph...c-2?wire=3 .

Aegean Marine Petroleum Network Inc. (NYSE: ANW ) Lead Plaintiff Deadline: August 6, 2018       Class Period: April 28, 2016 - June 4, 2018

Allegations: Aegean had improperly accounted for an approximate $200 million of accounts receivable as of December 31, 2017; Aegean failed to maintain effective internal control over financial reporting; and as a result of the foregoing, Defendants’ statements about Aegean’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Get additional information: http://www.kleinstocklaw.com/pslra-c/aegean-m...inc?wire=3 .

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arkestro Recognized as Leading Sourcing Tech Solution in 2024

Updated Category News Views 138

Arkestro Celebrated as a Leading Sourcing Technology Provider Arkestro's innovative Predictive Procurement Orchestration AI platform has been recognized among the top contenders in the industry. This recognition comes as part of Spend Matters' release of their Fall 2024 SolutionMap, which acknowledges the leading procurement technology vendors. Out of 93 companies...

Continue Reading
Nanoscope Therapeutics Welcomes Ademola Daramola as VP of Quality

Updated Category News Views 178

Nanoscope Therapeutics Expands Leadership Team Nanoscope Therapeutics Inc., a dedicated biotechnology firm, strives to restore vision for blind patients through pioneering gene therapies. The company has recently appointed Ademola Daramola, D.Sc., as the Vice President of Quality and Compliance. Introducing Dr. Ademola Daramola Dr. Daramola joins Nanoscope with an...

Continue Reading
Lumentum Holdings Readies for Earnings Report with Optimism

Updated Category News Views 220

Lumentum Holdings Prepares for Earnings Release Lumentum Holdings (NASDAQ: LITE) is set to announce its quarterly earnings soon. Investors are eager to see what insights will emerge from the report, as expectations build around the company's performance. Investor Expectations and Earnings Forecast Analysts predict that Lumentum Holdings will post an earnings per share...

Continue Reading
LightPath Technologies Launches Infrared Solutions for Defense

Updated Category News Views 130

LightPath Technologies Initiates Delivery of Infrared Assemblies FPV Drone Infrared Lens Assemblies for European Defense Customer Expected to Drive $1.0-2.0 Million in Revenue in Calendar Year 2025 LightPath Technologies, Inc. (NASDAQ: LPTH), renowned for its advanced optics and imaging systems targeted at both defense and commercial utilizations, has announced that it...

Continue Reading
The RealReal Boosts Revenue and Adjusted EBITDA in Q3 2024

Updated Category News Views 57

Strong Q3 2024 Performance for The RealReal The RealReal (NASDAQ: REAL), a leader in the online marketplace for authenticated, resale luxury goods, reported significant financial gains in the third quarter of 2024. The company achieved a revenue of $148 million, which represents an increase of $15 million or 11% compared to the previous year. Notably, they also saw...

Continue Reading